✦ LIBER ✦

P-220 Polymorphisms in DNA repair genes and survival in cisplatin (cis)/docetaxel (doc)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): a Spanish Lung Cancer Group phase II trial

✍ Scribed by Isla, Dolores; Queralt, Cristina; Alonso, Guillermo; Domine, Manuel; Barcelo, Ramon; Camps, Carlos; Lopez-Brea, Marta; Paredes, Alfredo; Barneto, Isidoro; Rosell, Rafael

Book ID: 118571921
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 174 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92189-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-224 XPD polymorphisms in cisplatin (ci

P-224 XPD polymorphisms in cisplatin (cis)/vinorelbine (vrb)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): genetic analysis of a Spanish Lung Cancer Group phase II trial

✍ Vin˜olas, Nuria; Roig, Barbara; Reguart, Noemi; Provencio, Mariano; Cardenal, Fe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

P-225 XPD and RRM1 gene polymorphisms pr

P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901

✍ Sarries, Carme; Garrido, Pilar; Nun˜ez, Laura; Roig, Barbara; Ramirez, Jose Luis 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

P-205 Lack of b-tubulin gene mutations i

P-205 Lack of b-tubulin gene mutations in docetaxel (doc)/cisplatin (cis)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p) at time of tumor progression

✍ Queralt, Cristina; Roig, Barbara; Sarries, Carme; Botia, Monica; Nun˜ez, Laura; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 233 KB

A randomized phase III trial of docetaxe

A randomized phase III trial of docetaxel (D) and cisplatin (P) versus vindesine (V) and p in stage IV non small cell lung cancer (NSCLC)

✍ Y. Nishiwaki; H. Kunitoh; K. Noda; Y. Ichinose; N. Katakami; T. Sugiura; M. Kawa 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 163 KB

O-089 ERCC1 mRNA-based randomized phase

O-089 ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p)

✍ Cobo, M.; Isla, D.; Sánchez, J.; Massuti, B.; Montes, A.; Paz-Ares, L.; Múñoz, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

157 Phase II trial of vinorelbine (NVB)

157 Phase II trial of vinorelbine (NVB) and cisplatin (CDDP) in stage III–IV non-small cell lung cancer (NSCLC)

✍ Pawlicki, M.; Krawczyk, K.; Zych, J.; Kowal, A.; Rolski, J.; Rowinska-Zakrzewska 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 308 KB